News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Institute For The Study Of Aging And Elan Pharmaceuticals (ELN) Announce Winners Of New Alzheimer's Disease Drug Discovery Award Program


3/1/2006 2:52:14 PM

The Institute for the Study of Aging (ISOA), a biomedical venture philanthropy founded by the Estee Lauder family, and Elan Pharmaceuticals, Inc., a neuroscience-based biotechnology company, are pleased to announce the winners of their new research award program, Novel Approaches to Drug Discovery for Alzheimer's Disease. Four recipients were selected from a highly competitive pool of 45 scientists from 12 countries.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES